Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.31 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1003042 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL8935090 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL13843579 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL29521285 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| Sulfuric Acid SCHEMBL4926135 | 0.90 | MEN1 (0.41) | MEN1KMT2ATSHRMAPK1THRB | |
| Sulfuric Acid SCHEMBL4916797 | 0.90 | MEN1 (0.41) | MEN1KMT2ATSHRMAPK1THRB | |
| Sulfuric Acid SCHEMBL4917301 | 0.90 | MEN1 (0.41) | MEN1KMT2ATSHRMAPK1THRB | |
| Sulfuric Acid SCHEMBL4927490 | 0.90 | MEN1 (0.41) | MEN1KMT2ATSHRMAPK1THRB | |
| Sulfuric Acid SCHEMBL4925364 | 0.90 | MEN1 (0.41) | MEN1KMT2ATSHRMAPK1THRB | |
| Sulfuric Acid SCHEMBL4926032 | 0.90 | MEN1 (0.41) | MEN1KMT2ATSHRMAPK1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108779419-B | Cleaning agent composition for electronic material, cleaning agent stock solution, and method for cleaning electronic material | 荒川化学工业株式会社 | 2021-04-20 | — | — | CN | disclosed |
| WO-2011082487-A1 | BISPHENOL DERIVATIVES AND THEIR USE AS ANDROGEN RECEPTOR ACTIVITY MODULATORS | BRITISH COLUMBIA CANCER AGENCY BRANCH (CA) | 2011-07-14 | — | — | WO | disclosed |
| US-7867623-B2 | Polymeric particles capable of absorbing blood and/or body fluids | BASF AKTIENGESELLSCHAFT | 2011-01-11 | — | — | US | disclosed |
| US-20110003685-A1 | Polymeric Particles Capable of Absorbing Blood and/or Body Fluids | BASF SE (DE) | 2011-01-06 | — | — | US | disclosed |
| US-7528179-B2 | Block polymer, polymer-containing composition containing the same, ink composition and liquid applying method and liquid applying apparatus utilizing the polymer-containing composition | CANON KABUSHIKI KAISHA (JP) | 2009-05-05 | — | — | US | disclosed |
| US-7306664-B2 | Ink-jet recording ink, ink-jet recording method, and ink-jet recording apparatus | CANON KABUSHIKI KAISHA (JP) | 2007-12-11 | — | — | US | disclosed |
| US-20070112222-A1 | Polymeric particles capable of absorbing blood and/or body fluids | BASF AKTIENGESELLSCHAFT (DE) | 2007-05-17 | — | — | US | disclosed |
| EP-1038929-B1 | Aqueous ink composition and printing method using same | SEIKO EPSON CORP (JP) | 2003-07-09 | — | — | EP | disclosed |
| US-6231655-B1 | MIXTURE OF WATER, DYE AND POLYOXYALKYLENATED POLYFLUOROISOPROPYLIDENE GLYCOL | SEIKO EPSON CORPORATION (JP) | 2001-05-15 | — | — | US | disclosed |
| EP-1038929-A1 | Aqueous ink composition and printing method using same | SEIKO EPSON CORPORATION (JP) | 2000-09-27 | — | — | EP | disclosed |
| EP-0769537-B1 | Ink composition having excellent waterfastness | SEIKO EPSON CORP (JP) | 2000-02-02 | — | — | EP | disclosed |
| US-5932631-A | BLEND CONTAINING ALKALI SOLUBLE POLYMER | SEIKO EPSON CORPORATION (JP) | 1999-08-03 | — | — | US | disclosed |
| EP-0769537-A2 | Ink composition having excellent waterfastness | SEIKO EPSON CORPORATION (JP) | 1997-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070112222-A1 | Polymeric particles capable of absorbing blood and/or body fluids | EPCAM, SELP, APOB | MEN1 1394/4885KMT2A 2777/4885TSHR 3742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.